Contract Option Exercises — June 28, 2026

Emergent Biosolutions' ACAM2000 smallpox vaccine contract extends to 2029 with $457.9M already outlayed, providing a strong revenue floor and signaling sustained government commitment to biodefense preparedness under HHS/ASPR.

The $1.31B award to SLS Federal Services from the Department of Homeland Security represents a significant new defense-related contract, though limited data on pricing and competition reduces conviction.

CGS Administrators' $339.5M CMS contract has negative actual outlays (-$762k), suggesting potential underperformance, termination risk, or renegotiation – bearish for service stability in the Medicare administration sector.

Emergent's $857.6M firm fixed-price contract shifts all cost overrun risk to the company; any manufacturing delays or input cost inflation could compress margins on this decade-long commitment.

CGS Administrators' contract shows -$762k in outlays against a $339.5M base, indicating potential funding clawback, performance issues, or program cancellation – a red flag for CMS administrative services.

The $1.31B DHS award lacks pricing type, competition history, and competitive moat data – investors cannot assess contract durability or protest risk, limiting actionable analysis.

Emergent's $857.6M ACAM2000 contract provides $85.8M annualized revenue over 10 years, with the outlay pace suggesting potential acceleration if option exercises increase.

The $1.31B SLS Federal Services award represents a large, first-reported contract with DHS, potentially opening a new revenue stream for the company if pricing and competition details become favorable.

Two HHS contracts totaling $1.2B (48% of aggregate) underscore sustained government investment in biodefense and health preparedness, with Emergent's ACAM2000 vaccine contract as the anchor.

CGS Administrators' CMS contract with a negative outlay (-$762k) signals potential turbulence in Medicare administrative services, which could benefit competitors with cleaner execution records.

{"entity"=>"Emergent Biosolutions", "reason"=>"ACAM2000 contract has $457.9M outlayed, leaving $399.7M available; slow outlay could indicate program delays, while acceleration would signal strong execution.", "trigger"=>"Option exercise announcements; outlay pace updates; NDAA provisions for biodefense"}

{"entity"=>"SLS Federal Services", "reason"=>"Undisclosed contract details on $1.31B DHS award create uncertainty; any clarification on pricing type or competition would increase conviction.", "trigger"=>"Contract modification announcements; protest filing or resolution"}

{"entity"=>"CGS Administrators", "reason"=>"Negative outlay on $339.5M CMS contract suggests possible termination or renegotiation; resolution would clarify remaining value.", "trigger"=>"Outlay trend updates; termination announcement; CMS follow-on award"}